Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2Other 2

Conditions

Obesity 218Neoplasms 73Breast Neoplasms 66Overweight 65Sexual Dysfunction, Physiological 51Motor Activity 43Polycystic Ovary Syndrome 42Weight Loss 32Mucositis 29Dyspnea 28Prostatic Neoplasms 22Multiple Endocrine Neoplasia Type 1 16Constipation 15Lung Neoplasms 14Endometrial Neoplasms 14Diabetes Mellitus 14Anxiety Disorders 14Sedentary Behavior 13Depression 13Sexual Dysfunctions, Psychological 12Cardiovascular Diseases 12Pain 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Fatigue 10Diabetes Mellitus, Type 2 10Colorectal Neoplasms 10Sexuality 9Obesity, Morbid 9Insulin Resistance 9Head and Neck Neoplasms 9

Interventions

Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Methods 1Massage 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Chemotherapy-Induced Peripheral Neuropathy × Other × Clear all
NCT06945380 2026-05-06

Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

Mayo Clinic

Phase NA Recruiting
300 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

NCT07365007 2026-03-03

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

University of Michigan Rogel Cancer Center

Phase NA Recruiting
50 enrolled
OtherOther solid neoplasm

Chemotherapy-Induced Peripheral Neuropathy

Data powered by HemOnc (CC BY 4.0) Colophon âš¡